Rogala, P.; Czarnecka, A.M.; Cybulska-Stopa, B.; Ostaszewski, K.; Piejko, K.; Ziętek, M.; Dziura, R.; Rutkowska, E.; Galus, Ł.; Kempa-Kamińska, N.;
et al. Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients. Cancers 2022, 14, 2123.
https://doi.org/10.3390/cancers14092123
AMA Style
Rogala P, Czarnecka AM, Cybulska-Stopa B, Ostaszewski K, Piejko K, Ziętek M, Dziura R, Rutkowska E, Galus Ł, Kempa-Kamińska N,
et al. Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients. Cancers. 2022; 14(9):2123.
https://doi.org/10.3390/cancers14092123
Chicago/Turabian Style
Rogala, Paweł, Anna M. Czarnecka, Bożena Cybulska-Stopa, Krzysztof Ostaszewski, Karolina Piejko, Marcin Ziętek, Robert Dziura, Ewa Rutkowska, Łukasz Galus, Natasza Kempa-Kamińska,
and et al. 2022. "Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients" Cancers 14, no. 9: 2123.
https://doi.org/10.3390/cancers14092123
APA Style
Rogala, P., Czarnecka, A. M., Cybulska-Stopa, B., Ostaszewski, K., Piejko, K., Ziętek, M., Dziura, R., Rutkowska, E., Galus, Ł., Kempa-Kamińska, N., Seredyńska, J., Bal, W., Kozak, K., Surus-Hyla, A., Kubiatowski, T., Kamińska-Winciorek, G., Suwiński, R., Mackiewicz, J., & Rutkowski, P.
(2022). Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients. Cancers, 14(9), 2123.
https://doi.org/10.3390/cancers14092123
